Tyme Technologies (TYME) Prices 40M Share Registered Direct Common Offering at $2.50/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. RXO
10. AMD

Go back to Tyme Technologies (TYME) Prices 40M Share Registered Direct Common Offering at $2.50/Sh

Pre-Open Stock Movers 02/03: (TYME) (GWPH) (GOOGL) Higher; (VXRT) (VYGR) (TENB) Lower (more...)

February 3, 2021 9:24 AM EST

Pre-Open Stock Movers:

Tyme Technologies, Inc. (NASDAQ: TYME) 60% HIGHER; announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Companys metabolomic technology platform. The patent, U.S. Patent No. 10,905,698, is directed to methods for treating COVID-19.

Vaxart, Inc., (NASDAQ: VXRT) 53.2% LOWR; announced preliminary data from its Phase 1 study of VXA-CoV2-1... More

Tyme Technologies (TYME) Climbs 110%

February 3, 2021 8:17 AM EST

Tyme Technologies (NASDAQ: TYME) Climbs 110%

Earlier Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections... More

Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

February 3, 2021 8:07 AM EST

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Companys metabolomic technology platform. The patent, U.S.... More